NEWS
View news from our Featured Companies.
ARIANNE PHOSPHATE EXPLORING THE USE OF PHOSPHATE IN HYDROGEN-BASED TECHNOLOGIES
-Company is working with the University of Quebec at Three-Rivers in the use of phosphate in electrolysers and energy cells DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGUENAY, QC, Dec. 15, 2021 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne")...
Kiora Pharmaceuticals Appoints David Hollander, MD, MBA, to its Board of Directors
Salt Lake City, Utah--(December 15, 2021) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announced the appointment of David Hollander, MD, MBA, to its Board of Directors. Dr. Hollander, who currently serves as the Chief Research and...
Kiora Reports KIO-101 is Safe and Tolerable; Topline Data Supports Advancing KIO-101 to a Phase 2 Study in Patients with Dry Eye Disease
Salt Lake City, Utah--(December 14, 2021) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced topline data from its vehicle-controlled, randomized safety study of KIO-101 eyedrops. The study evaluated 24 healthy subjects and 21 patients...
Mogo Announces Closing of US$27.5 Million Registered Direct Offering
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a financial technology, digital payments and crypto company, announced today that it has closed its previously announced sale to certain institutional investors of an aggregate...
Aytu BioPharma Announces FDA Clearance of Investigational New Drug (IND) Application for AR101/Enzastaurin in Vascular Ehlers-Danlos Syndrome
Pivotal clinical trial will begin in first half of 2022ENGLEWOOD, CO / December 13, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced that the U.S. Food...
INVO Bioscience to Participate in the Lytham Partners Winter 2021 Investor Conference
SARASOTA, Fla., Dec. 10, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, announced today that it will be participating in the Lytham Partners Winter 2021...
LiqTech International to Participate in the Lytham Partners Winter 2021 Investor Conference
BALLERUP, Denmark, Dec. 9, 2021 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, announced today that it will be participating in the Lytham Partners Winter...
S&W to Participate in the Lytham Partners Winter 2021 Investor Conference
LONGMONT, Colo., Dec. 9, 2021 -- S&W Seed Company (Nasdaq: SANW) announced today that it will be participating in the Lytham Partners Winter 2021 Investor Conference taking place from December 13-16, 2021. During the event, the company will be participating in a...
Mogo Announces US$27.5 Million Registered Direct Offering
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a financial technology, digital payments and crypto company, announced today that it has entered into definitive agreements with certain institutional investors for the sale of...
Scientific Industries Announces BioMADE and Scientific Bioprocessing Partnership to Bring Digitally Simplified Bioprocessing to 20 U.S. Colleges
BOHEMIA, NY / December 9, 2021 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider and developer of digitally simplified bioprocessing products, today announced that Scientific Bioprocessing, Inc. (SBI) has formed a unique partnership with...
Aytu BioPharma Receives Orphan Drug Designation from FDA for AR101 for Treatment of Vascular Ehlers-Danlos Syndrome
ENGLEWOOD, CO / December 8, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has granted...
Scientific Industries to Participate in the Lytham Partners Winter 2021 Investor Conference
BOHEMIA, NY / December 6, 2021 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today that it will be participating in the Lytham Partners Winter 2021 Investor...
SenesTech to Participate in the Lytham Partners Winter 2021 Investor Conference
PHOENIX, Dec. 6, 2021 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will be participating in the Lytham Partners Winter 2021 Investor Conference taking...
Zoomd Technologies to Participate in the Lytham Partners Winter 2021 Investor Conference
VANCOUVER, BC, Dec. 6, 2021 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC-PINK: ZMDTF) ("Zoomd" or the "Company"), a leading provider of an online advertising robust marketing platform that focuses on improving customers user acquisition campaigns, announced...
INVO Bioscience Obtains Regulatory Approval to Commercialize INVOcell In Thailand
INVO's distribution partner, IVF Envimed Company Ltd., set to begin commercialization of the INVOcell system within Thailand.SARASOTA, Fla., Dec. 1, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in...
Jewett-Cameron Announces Fiscal 2021 Financial Results
NORTH PLAINS, Ore., Nov. 29, 2021 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF) today reported financial results for its fourth quarter and fiscal year ended August 31, 2021. For the fiscal year ended August 31, 2021, Jewett-Cameron had sales of $57.5 million...
Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc.
SAN DIEGO, CA / November 29, 2021 / Modular Medical, Inc. (the "Company" or "Modular Medical") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes...
Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital Market
SAN DIEGO, CA / November 26, 2021 / Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians...
LiqTech International Appoints Simon Stadil as Chief Financial Officer
Claus Toftegaard Becomes Project Director Overseeing the Company's Expansion Projects in China and DenmarkBALLERUP, Denmark, Nov. 23, 2021 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly...
Mogo Adds to Strategic Investment Portfolio with Minority Investment in Gemini
Winklevoss-led company raises US$400 million to help build decentralized metaverse Mogo's ~ $150 million portfolio includes strategic investments in crypto platforms, digital assets and gaming VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or...
Aytu BioPharma Announces Issuance of First U.S. Patent Supporting Healight Ultraviolet-A Respiratory Catheter
ENGLEWOOD, CO / November 23, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced that today the United States Patent and Trademark Office (USPTO) has...
Zoomd Delivered A Fourth Consecutive Quarter Of Growth In Both Revenue And Adjusted EBITDA, Achieving An Adjusted EBITDA Increase Of More Than US$5m For The Nine Months Ended September 30, 2021 Compared To The Same Period In 2020[1]
Achieving a record revenue per quarter of US16M and a record revenue growth rate of 141% YOYVANCOUVER, BC, Nov. 22, 2021 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) ("Zoomd" or the "Company"), a leading provider of an online advertising robust marketing...
PolyPid Announces 500th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX in Abdominal Surgery
Company Continues to Expect that the Last Patient Will be Enrolled in the Second Quarter of 2022, Followed by Top-Line Results Two Months ThereafterPETAH TIKVA, Israel, Nov. 18, 2021 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a phase 3...
Arianne Phosphate Reports Corporate and Financial Results for Third Quarter 2021
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGUENAY, QC, Nov. 17, 2021 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
Aytu BioPharma Ranked Number 178 Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 50™
ENGLEWOOD, CO / November 17, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced it ranked 178 on the Deloitte Technology Fast 500™, a...